| dc.contributor.author | Henderson, DR | |
| dc.contributor.author | de Souza, NM | |
| dc.contributor.author | Parker, CC | |
| dc.contributor.author | van As, NJ | |
| dc.date.accessioned | 2017-03-01T11:36:15Z | |
| dc.date.issued | 2016-06 | |
| dc.identifier.citation | European urology, 2016, 69 (6), pp. 1037 - ? | |
| dc.identifier.issn | 0302-2838 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/418 | |
| dc.identifier.eissn | 1873-7560 | |
| dc.identifier.doi | 10.1016/j.eururo.2015.11.027 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 1037 - ? | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.subject | Humans | |
| dc.subject | Prostatic Neoplasms | |
| dc.subject | Prostate-Specific Antigen | |
| dc.subject | Male | |
| dc.title | Reply from Authors re: Tillmann Loch, Pat Fox Fulgham. Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow. Eur Urol 2016;69:1034-6: Imaging in Active Surveillance for Prostate Cancer: Where Should We Focus Our Research? | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2015-11-23 | |
| rioxxterms.versionofrecord | 10.1016/j.eururo.2015.11.027 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2016-06 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | European urology | |
| pubs.issue | 6 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy/Stereotactic and Precision Body Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy/Stereotactic and Precision Body Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 69 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Stereotactic and Precision Body Radiotherapy | en_US |
| dc.contributor.icrauthor | Parker, Chris | |
| dc.contributor.icrauthor | van As, Nick | |
